S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
Buy THIS stock before Taiwan is attacked (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
MarketBeat Week in Review – 9/25 - 9/29
Elon Did It Again: This Could be Bigger than Tesla (Ad)
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Elon Did It Again: This Could be Bigger than Tesla (Ad)
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
California Gov. Gavin Newsom rejects bill that would have given unemployment checks to some striking workers
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
Buy THIS stock before Taiwan is attacked (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
MarketBeat Week in Review – 9/25 - 9/29
Elon Did It Again: This Could be Bigger than Tesla (Ad)
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Elon Did It Again: This Could be Bigger than Tesla (Ad)
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
California Gov. Gavin Newsom rejects bill that would have given unemployment checks to some striking workers
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
Buy THIS stock before Taiwan is attacked (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
MarketBeat Week in Review – 9/25 - 9/29
Elon Did It Again: This Could be Bigger than Tesla (Ad)
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Elon Did It Again: This Could be Bigger than Tesla (Ad)
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
California Gov. Gavin Newsom rejects bill that would have given unemployment checks to some striking workers
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
Buy THIS stock before Taiwan is attacked (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
MarketBeat Week in Review – 9/25 - 9/29
Elon Did It Again: This Could be Bigger than Tesla (Ad)
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Elon Did It Again: This Could be Bigger than Tesla (Ad)
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
California Gov. Gavin Newsom rejects bill that would have given unemployment checks to some striking workers
NYSEARCA:IHE

iShares U.S. Pharmaceuticals ETF (IHE) Price, Holdings, & News

$176.98
-1.28 (-0.72%)
(As of 09/29/2023 ET)
Compare
Today's Range
$176.76
$179.07
50-Day Range
$176.91
$191.38
52-Week Range
$166.99
$191.74
Volume
5,794 shs
Average Volume
8,167 shs
Market Capitalization
$362.81 million
Assets Under Management
$353.91 million
Dividend Yield
2.11%
Net Expense Ratio
0.39%

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors.

IHE Price History

IHE ETF News Headlines

The Zacks Analyst Blog Highlights URNJ, IHE and PXE
Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
Pharma ETF (IHE) Hit a 52-Week High
Pharma ETFs Gain Post Q1 Earnings
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
How to Invest in Johnson & Johnson Stock
See More Headlines
Receive IHE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares U.S. Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
iShares
Fund Name
iShares U.S. Pharmaceuticals ETF
Tax Classification
Regulated Investment Company
Current Symbol
NYSEARCA:IHE
Inception Date
5/1/2006
Fund Manager
Diane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
Dow Jones U.S. Select Pharmaceuticals Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
38

Fund Statistics

Assets Under Management
$353.91 million
Average Daily Volume
$19,287.40
Discount/Premium
0.02%

Administrator, Advisor and Custodian

Administrator
Citibank, N.A.
Advisor
BlackRock Fund Advisors
Custodian
Citibank, N.A.
Distributor
BlackRock Investments, LLC
Transfer Agent
Citibank, N.A.
Trustee
N/A
Lead Market Maker
Latour Trading

Options

Optionable
N/A
Short Interest
13,200 shs

Miscellaneous

Beta
0.70
Creation Unit
50,000
Creation Fee
$306.00
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

iShares U.S. Pharmaceuticals ETF Expenses

TypeIHEHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.39%0.57%0.53%0.50%0.50%
Other Expenses0.00%0.40%0.52%0.64%0.57%
Total Expense0.39%0.72%0.69%0.74%0.69%
Fee Waiver0.00%-0.51%-0.55%-0.70%-0.59%
Net Expense0.39%0.61%0.59%0.57%0.57%

iShares U.S. Pharmaceuticals ETF (IHE) Holdings & Exposure

Key Executives

  • George G. C. Parker Ph.D. (Age 78)
    Independent Chairman of the Board of Trustees
  • Michael Arthur Latham (Age 51)
    President, Trustee
  • Jack Gee (Age 57)
    Chief Financial Officer, Treasurer
  • Geoffrey D. Flynn
    Chief Operating Officer, Executive Vice President
  • Amy Schioldager (Age 56)
    Executive Vice President
  • Ira P. Shapiro (Age 52)
    Vice President, Chief Legal Officer
  • Matt Tucker
    Vice President
  • Eilleen M. Clavere (Age 61)
    Secretary
  • Cecilia H. Herbert (Age 68)
    Independent Trustee
  • Charles A. Hurty (Age 73)
    Independent Trustee













IHE ETF - Frequently Asked Questions

How have IHE shares performed in 2023?

iShares U.S. Pharmaceuticals ETF's stock was trading at $186.13 at the beginning of 2023. Since then, IHE stock has decreased by 4.9% and is now trading at $176.9808.
View the best growth stocks for 2023 here
.

What does IHE invest in?

iShares U.S. Pharmaceuticals ETF is a equity fund issued by iShares. IHE focuses on health care investments and follows the Dow Jones U.S. Select Pharmaceuticals Index. The fund's investments total to approximately $353.91 million assets under management.

What stocks does iShares U.S. Pharmaceuticals ETF hold?
What is the management fee for iShares U.S. Pharmaceuticals ETF?

iShares U.S. Pharmaceuticals ETF's management fee is 0.39% and has no other recorded expenses or fee waivers. The net expense ratio for IHE is 0.39%.

What other stocks do shareholders of iShares U.S. Pharmaceuticals ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares U.S. Pharmaceuticals ETF investors own include United Parcel Service (UPS), CVS Health (CVS), Genuine Parts (GPC), Intel (INTC), Kinder Morgan (KMI), Wells Fargo & Company (WFC), Archer-Daniels-Midland (ADM), BP (BP) and Campbell Soup (CPB).

What is iShares U.S. Pharmaceuticals ETF's stock symbol?

iShares U.S. Pharmaceuticals ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "IHE."

How do I buy shares of iShares U.S. Pharmaceuticals ETF?

Shares of IHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iShares U.S. Pharmaceuticals ETF's stock price today?

One share of IHE stock can currently be purchased for approximately $176.98.

How much money does iShares U.S. Pharmaceuticals ETF make?

iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) has a market capitalization of $362.81 million.

This page (NYSEARCA:IHE) was last updated on 10/1/2023 by MarketBeat.com Staff

My Account -